HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 170 filers reported holding HAEMONETICS CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $816,434 | +17.7% | 9,114 | +11.9% | 0.00% | 0.0% |
Q2 2023 | $693,720 | +9.0% | 8,148 | +5.9% | 0.00% | 0.0% |
Q1 2023 | $636,679 | +17.5% | 7,694 | +11.7% | 0.00% | 0.0% |
Q4 2022 | $541,820 | +0.2% | 6,889 | -5.5% | 0.00% | 0.0% |
Q3 2022 | $541,000 | +4.2% | 7,290 | -8.4% | 0.00% | 0.0% |
Q2 2022 | $519,000 | -35.8% | 7,957 | -37.8% | 0.00% | 0.0% |
Q1 2022 | $809,000 | +22.9% | 12,802 | +3.1% | 0.00% | 0.0% |
Q4 2021 | $658,000 | -23.4% | 12,415 | +2.1% | 0.00% | 0.0% |
Q3 2021 | $859,000 | +36.8% | 12,159 | +29.0% | 0.00% | 0.0% |
Q2 2021 | $628,000 | -26.7% | 9,427 | +22.2% | 0.00% | 0.0% |
Q1 2021 | $857,000 | -27.9% | 7,717 | -22.9% | 0.00% | 0.0% |
Q4 2020 | $1,189,000 | +33.9% | 10,009 | -1.6% | 0.00% | 0.0% |
Q3 2020 | $888,000 | +41.0% | 10,173 | +44.7% | 0.00% | 0.0% |
Q2 2020 | $630,000 | -12.5% | 7,030 | -2.7% | 0.00% | 0.0% |
Q1 2020 | $720,000 | -6.2% | 7,224 | +7.9% | 0.00% | 0.0% |
Q4 2019 | $768,000 | -88.2% | 6,692 | -87.1% | 0.00% | -85.7% |
Q3 2019 | $6,536,000 | -22.8% | 51,815 | -26.4% | 0.01% | -12.5% |
Q2 2019 | $8,468,000 | +1242.0% | 70,364 | +876.1% | 0.01% | +700.0% |
Q1 2019 | $631,000 | +27.0% | 7,209 | +44.9% | 0.00% | 0.0% |
Q4 2018 | $497,000 | +3.5% | 4,975 | +19.0% | 0.00% | – |
Q3 2018 | $480,000 | +207.7% | 4,179 | +142.1% | 0.00% | – |
Q2 2018 | $156,000 | +11.4% | 1,726 | -9.9% | 0.00% | – |
Q1 2018 | $140,000 | +22.8% | 1,916 | -2.8% | 0.00% | – |
Q4 2017 | $114,000 | +32.6% | 1,972 | +2.5% | 0.00% | – |
Q3 2017 | $86,000 | +68.6% | 1,924 | +50.2% | 0.00% | – |
Q2 2017 | $51,000 | +10.9% | 1,281 | +11.4% | 0.00% | – |
Q1 2017 | $46,000 | +43.8% | 1,150 | +43.8% | 0.00% | – |
Q4 2016 | $32,000 | -8.6% | 800 | -18.8% | 0.00% | – |
Q3 2016 | $35,000 | -5.4% | 985 | -20.2% | 0.00% | – |
Q2 2016 | $37,000 | -15.9% | 1,234 | -1.0% | 0.00% | – |
Q1 2016 | $44,000 | +10.0% | 1,246 | +0.9% | 0.00% | – |
Q4 2015 | $40,000 | 0.0% | 1,235 | 0.0% | 0.00% | – |
Q3 2015 | $40,000 | -21.6% | 1,235 | +0.8% | 0.00% | – |
Q2 2015 | $51,000 | +4.1% | 1,225 | +12.4% | 0.00% | – |
Q1 2015 | $49,000 | -38.0% | 1,090 | -48.8% | 0.00% | – |
Q4 2014 | $79,000 | +92.7% | 2,130 | +85.2% | 0.00% | – |
Q3 2014 | $41,000 | 0.0% | 1,150 | 0.0% | 0.00% | – |
Q2 2014 | $41,000 | +10.8% | 1,150 | 0.0% | 0.00% | – |
Q1 2014 | $37,000 | -11.9% | 1,150 | +16.2% | 0.00% | – |
Q4 2013 | $42,000 | -10.6% | 990 | -14.7% | 0.00% | – |
Q3 2013 | $47,000 | +2.2% | 1,161 | +6.0% | 0.00% | – |
Q2 2013 | $46,000 | – | 1,095 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |